Monosaccharides

<p>Popular resource for chiral-pool based organic syntheses<br>Sold as an aqueous solution and by weight of active material</p>

<p>Methyl β-D-maltopyranoside is a disaccharide that is an aglycon of maltosides. It has been shown to bind to the active site of alpha-d-glucopyranosidases, which are enzymes that hydrolyze alpha-d-glucopyranosides. Methyl β-D-maltopyranoside has also been shown to interact with dihedral angles and hydroxyl groups in the enzyme binding region, which may be due to conformational changes in the enzyme's active site. The kinetic constants for methyl β-D-maltopyranoside have been calculated by using an algorithm.</p>

<p>4-Methylphenyl 2,3,4-tri-O-benzyl-b-L-thiofucopyranoside is a custom synthesis of an oligosaccharide. It is a complex carbohydrate with CAS No. that belongs to the class of saccharide and sugar. Polysaccharides are made up of several monosaccharides linked together by glycosidic bonds, which are formed by the action of enzymes called glycosyltransferases or glycosidases. Glycosylation is the process in which a sugar molecule (usually glucose) is added to another molecule by means of a glycosidic bond. Carbohydrates are one type of macromolecule and they are important sources of energy in living things. They also play important roles in cell walls and as structural components in plants and animals. The chemical modification carried out on this compound is methylation, which refers to the addition of one or more methyl</p>

<p>Glucal is a carbohydrate that is used as a synthon in organic synthesis. It has been shown to be anomeric and can be synthesized by acetylation of the corresponding aldose, or by the glycosidic bond reaction with borohydride reduction. Glucal is not stable at high pH and can undergo ring-opening reactions with nucleophiles such as sodium borohydride. Glucal also reacts with glycoconjugates to form new molecules, which are called glycosidic products.</p>

<p>N-acetyl D-glucosamine (GlcNAc) is an aldohexose (2-acetamido-2-deoxyglucose) in which the hydroxyl group at position 2 is replaced by NHAc (Collins, 2006). N-acetyl D-glucosamine forms the exoskeletons of molluscs and insects as the building block of the polysaccharide chitin (Rudrapatnam, 2003). N-acetyl D-glucosamine is a key component of N- and O-linked glycans, present in glycolipids and the glycosaminoglycan hyaluronic acid (Fallacara, 2018). A recent study has suggested that N-acetyl D-glucosamine may have therapeutic potential for COVID-19 as it affects the spike protein-ACE2 receptor interaction during the infection with SARS-CoV-2 virus (Baysal, 2021).</p>

<p>fucosylation inhibitor</p>

<p>sugar nucleotide</p>

<p>Butyl a-D-glucopyranoside is an antimicrobial agent that inhibits the growth of photosynthetic organisms. It has been shown to have high cytotoxicity against Gram-positive bacteria, including Enterobacter and Bacillus. Butyl a-D-glucopyranoside also exhibits strong antimicrobial activity against Gram-negative bacteria such as Escherichia coli, Salmonella enterica, Klebsiella pneumoniae, and Pseudomonas aeruginosa. This compound also has potent activity against fungi and yeast. The mechanism of action is not known but may involve the inhibition of tyrosol synthesis or the disruption of microbial membranes.</p>

<p>Building block for the synthesis of 2'-​C-​methyl substituted nucleosides</p>

<p>Phenyl 2-O-benzoyl-4,6-O-benzylidene-3-O-(2-naphthylmethyl)-b-D-thioglucopyranoside is a synthetic sugar with a complex carbohydrate structure. It has been modified by methylation, fluorination, and glycogenation. This product is used in the synthesis of saccharides and oligosaccharides for various purposes. Phenyl 2-O-benzoyl-4,6-O-benzylidene-3-- O-(2--naphthylmethyl)-b--D--thioglucopyranoside is CAS No. 1352561--95--5 and can be custom synthesized to meet your specifications.</p>

<p>D-Fucose is a sugar that can be synthesized in vitro. It is a component of the xanthurenic acid pathway, which is involved in the synthesis of l-arabinose. D-Fucose has been found to have anti-leukemic effects and to inhibit enzyme activities in vitro. It has also been shown to bind to the toll-like receptor, α1-acid glycoprotein, and surface membranes. A hydroxyl group at position 1 on the fucose molecule may be important for this binding. D-Fucose's biological properties are related to its structural analysis and the cell receptors it binds with. D-Fucose has an optimum pH level of 7, so it cannot survive outside of a neutral environment. It does not need any biological cofactors or enzymes for its synthesis, so it is classified as a nonessential nutrient. D-Fucose is also used in blood groups because it contains an antigen</p>

<p>2,7-Anhydro-D-sedoheptulose-2,3,4,5,6,7-13C6 is a custom synthesis of a complex carbohydrate. It is an oligosaccharide that is modified with methylation and glycosylation. This compound has been synthesized by Click modification and fluorination. 2,7-Anhydro-D-sedoheptulose-2,3,4,5,6,7-13C6 is water soluble and has a high purity. It is used as a research tool in the field of saccharides and carbohydrates.</p>

<p>Acetamido-2-deoxy-b-D-glucopyranosyl L-asparagine is used in studies of Aspartylglycosaminuria (AGU) which is a rare, inherited lysosomal storage disease caused by a deficiency in the enzyme aspartylglucosaminidase.</p>

<p>Custom synthesis of D-glucuronic acid, sodium salt monohydrate.</p>

<p>Isosorbide dinitrate is used to treat chronic bronchitis and congestive heart failure. It dilates blood vessels, allowing more oxygen-rich blood to reach the heart. Isosorbide dinitrate is also used to relieve chest pain (angina) and reduce complications after a heart attack. Isosorbide dinitrate is a prodrug that is converted in vivo to its active form, isosorbide mononitrate, by the enzyme nitric oxide synthase in response to hypoxia. In addition, it has been shown that this drug reduces levels of low-density lipoprotein cholesterol (LDL-C) and may be useful for the treatment of high cholesterol.<br>The mechanism of action for reducing LDL-C levels is not known but may be due to increased clearance of LDL-C from plasma or decreased production of very low density lipoproteins (VLDL). This medication does not affect triglycerides or high density lip</p>

<p>Ethyl 2,3,4-tri-O-benzyl-L-thiofucopyranoside is a glycosylation agent that is used in the synthesis of complex carbohydrates. It can also be used in the methylation and click modification of saccharides. Ethyl 2,3,4-tri-O-benzyl-L-thiofucopyranoside has been shown to have a high purity and can be custom synthesized to fit the needs of the customer. This product has a CAS number of 169532-17-6 and it is available in both monosaccharides and oligosaccharides.</p>

<p>N-Acetyl-L-talosaminuronic acid is a natural product that has been shown to have anti-inflammatory activity in experimental models of inflammatory bowel disease. N-Acetyl-L-talosaminuronic acid inhibits the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNFα), by binding to TNFα receptors on the surface of cells. This can be attributed to its ability to inhibit ATP levels and reduce oxidative stress, which are both factors that contribute to inflammation. N-Acetyl-L-talosaminuronic acid also has been shown to inhibit inflammatory responses in human monocytes and neutrophils. It binds specifically to her2+ breast cancer cells and inhibits their growth in culture. Furthermore, it has been shown to have cytotoxic effects on bladder cancer cells and can be used for the treatment of bladder cancer.</p>

<p>Intermediate in the synthesis of prostaglandins</p>

<p>L-Erythrose is a monosaccharide that contains an hydroxyl group on the second carbon atom. It can be synthesized by a synthetic scheme involving glycolaldehyde and hydroxylamine. L-Erythrose has been shown to inhibit the enzyme phosphoglycerate kinase, which converts 2-phosphoglycerate into phosphoenolpyruvate. L-Erythrose has also been shown to inhibit dehydroascorbic acid reductase, which converts dehydroascorbic acid into ascorbic acid, and galactitol reductase, which converts galactitol into D-tagatose. The mutant strain of Escherichia coli K12 that was engineered to produce L-erythrose showed a decreased susceptibility to phage infection and an increased resistance to oxidative stress. In addition, the polyol pathway in E. coli was induced by L-erythrose treatment.</p>

<p>Used for preparation of biologically active compounds</p>